SCHEMBL2502889

SCHEMBL2502889

CCC[C@H](CC(=O)O)c1ccc(C)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.46
PTGS1 P23219 1/20 0.46
CACNA1C Q13936 1/20 0.46
GAA P10253 2/20 0.44
LMNA P02545 3/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2D6 P10635 3/20 0.39
CYP2C19 P33261 3/20 0.39
MEN1 O00255 2/20 0.39
CYP3A4 P08684 2/20 0.39
KMT2A Q03164 2/20 0.39
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
GABBR2 O75899 4/20 0.36
GABBR1 Q9UBS5 4/20 0.36
FFAR1 O14842 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2498025 1.00 TRPA1 (0.46) TRPA1PTGS1CACNA1CGAALMNA
SCHEMBL3873634 0.88 GAA (0.47) GAALMNAALDH1A1CYP2C9CYP1A2
SCHEMBL3654833 0.88 GAA (0.49) TRPA1PTGS1CACNA1CGAALMNA
SCHEMBL3652899 0.88 GAA (0.49) TRPA1PTGS1CACNA1CGAALMNA
SCHEMBL2495292 0.84 ADRB1 (0.43) GAALMNACYP2C9CYP1A2CYP2D6
SCHEMBL2501254 0.84 ADRB1 (0.43) GAALMNACYP2C9CYP1A2CYP2D6
SCHEMBL3879416 0.82 GAA (0.47) GAALMNACYP2C9CYP1A2CYP2D6
SCHEMBL2497024 0.81 GAA (0.53) GAAALDH1A1FFAR1
SCHEMBL2503228 0.81 GAA (0.53) GAAALDH1A1FFAR1
SCHEMBL3872457 0.79 ESR1 (0.59) PTGS1GAALMNACYP2C9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed